<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="high levels of herpes simplex virus (HSV) replication, treatment with" exact="acyclovir" post="was associated with longer time to death and improved"/>
 <result pre="the group of patients with antibiotics resistant VAP and an" exact="acyclovir" post="therapy in this highly selected patient group. From our"/>
 <result pre="difficult explanation of viral load by the quantitative PCR. Moreover," exact="acyclovir" post="treatment was associated with a significantly improved circulatory function"/>
 <result pre="Finally, in Schuierer’s report [1], the treated patients required lower" exact="norepinephrine" post="doses than untreated patients on baseline, and the treated"/>
 <result pre="viral disease before initiation of treatment. Moreover, our result that" exact="acyclovir" post="is effective in these patients suggests—a posteriori—that HSV may"/>
 <result pre="that they have no competing interests. References References 1.SchuiererLGebhardMRufHGJaschinskiUBerghausTMWittmannMBraunGBuschDHHoffmannRImpact of" exact="acyclovir" post="use on survival of patients with ventilator-associated pneumonia and"/>
</results>
